Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...

Health-care companies fell amid mixed earnings. Shares of Danaher, which makes tools and equipment for the biotech, life-sciences and diagnostics businesses, plunged by roughly 10% after it posted ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Nvidia (NASDAQ: NVDA) roared higher last year, gaining more than 170%, and emerged as the key player in the artificial ...

The private-equity firm KKR has taken a big stake in the medical- and dental-supply company Henry Schein and plans to work ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...

KKR plans to announce a deal that includes increasing its stake to 12% with the option to buy up to an additional 2.9% in the ...

NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors ...

Ananym Capital Management, an activist investor, has plans to nominate up to six directors to the board of Henry Schein ...

Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC) and could ...

Activist investor Ananym Capital Management to nominate directors to Henry Schein board, pushing for CEO change and cost ...